Psoriasis and non-alcoholic fatty liver disease

Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies

(2010) S Prey et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Hepatitis B virus reactivation during therapy with etanercept in an HBsAg-negative and anti-HBs-positive patient

(2010) Pilar Martinez Montiel et al.   LIVER INTERNATIONAL

Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome

(2009) C. H. KIM et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Autoimmune hepatitis associated with infliximab in a patient with palmoplantar pustular psoriaisis

(2009) D. A. Fairhurst et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Molecular pathophysiology of psoriasis and molecular targets of antipsoriatic therapy

(2009) Emőke Rácz et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Adalimumab-induced Autoimmune Hepatitis

(2009) Tomer Adar et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis

(2009) Paolo Gisondi et al.   JOURNAL OF HEPATOLOGY

Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis

(2009) Luca Miele et al.   JOURNAL OF HEPATOLOGY

Guidelines of care for the management of psoriasis and psoriatic arthritis

(2009) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference

(2009) Robert E. Kalb et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers

(2009) M. A. Edens et al.   Obesity Reviews

Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis

(2008) Anna Wieckowska et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Psoriasis Independently Associated With Hyperleptinemia Contributing to Metabolic Syndrome

(2008) Yi-Ju Chen et al.   ARCHIVES OF DERMATOLOGY

Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk

(2008) Jean-Pierre Després et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation

(2008) A. Johnston et al.   BRITISH JOURNAL OF DERMATOLOGY

Serum leptin levels, skin leptin and leptin receptor expression in psoriasis

(2008) A.A. Çerman et al.   BRITISH JOURNAL OF DERMATOLOGY

Psoriasis is associated with increased levels of serum leptin

(2008) Y. Wang et al.   BRITISH JOURNAL OF DERMATOLOGY

Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations

(2008) David Preiss et al.   CLINICAL SCIENCE

Association between Psoriasis and the Metabolic Syndrome

(2008) A.D. Cohen et al.   DERMATOLOGY

Psoriasis comorbidities

(2008) Alice B. Gottlieb et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

(2008) Craig L Leonardi et al.   LANCET

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

(2008) Kim A Papp et al.   LANCET

The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective

(2008) Mariana Lazo et al.   SEMINARS IN LIVER DISEASE

New-Onset Diabetes Mellitus After Kidney Transplantation: The Role of Immunosuppression

(2008) M. Veroux et al.   TRANSPLANTATION PROCEEDINGS

Adalimumab Could Suppress the Activity of Non Alcoholic Steatohepatitis (NASH)

(2008) C Schramm et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE